144 results on '"Citron, Michael"'
Search Results
2. Stabilized trimeric peptide immunogens of the complete HIV-1 gp41 N-heptad repeat and their use as HIV-1 vaccine candidates.
3. A Novel Rotavirus Reverse Genetics Platform Supports Flexible Insertion of Exogenous Genes and Enables Rapid Development of a High-Throughput Neutralization Assay
4. A novel method for strict intranasal delivery of non-replicating RSV vaccines in cotton rats and non-human primates
5. Modified mRNA/lipid nanoparticle-based vaccines expressing respiratory syncytial virus F protein variants are immunogenic and protective in rodent models of RSV infection
6. A potent broadly neutralizing human RSV antibody targets conserved site IV of the fusion glycoprotein
7. Preclinical immunogenicity and efficacy of a candidate COVID-19 vaccine based on a vesicular stomatitis virus-SARS-CoV-2 chimera
8. Characterization of humoral and cell-mediated immunity induced by mRNA vaccines expressing influenza hemagglutinin stem and nucleoprotein in mice and nonhuman primates
9. Human neutrophil elastase detection with fluorescent peptide sensors conjugated to cellulosic and nanocellulosic materials: part II, structure/function analysis
10. Upper and lower respiratory tract correlates of protection against respiratory syncytial virus following vaccination of nonhuman primates
11. Design of an HA2-based Escherichia coli expressed influenza immunogen that protects mice from pathogenic challenge
12. Vaccination with peptide mimetics of the gp41 prehairpin fusion intermediate yields neutralizing antisera against HIV-1 isolates
13. Vaccine Hyporesponse Induced by Individual Antibiotic Treatment in Mice and Non-Human Primates Is Diminished upon Recovery of the Gut Microbiome
14. Transplacental Antibody Transfer of Respiratory Syncytial Virus Specific IgG in Non-Human Primate Mother-Infant Pairs
15. Comparative immunogenicity evaluations of influenza A virus M2 peptide as recombinant virus like particle or conjugate vaccines in mice and monkeys
16. Responding kinetic of B-cell receptor repertoire to the Toll-like receptor 7/8 stimulation in non-human primates
17. Upper and Lower Respiratory Tract Correlates of Protection Against RSV Following Vaccination of Non-Human Primates
18. Immunogenicity generated by mRNA vaccine encoding VZV gE antigen is comparable to adjuvanted subunit vaccine and better than live attenuated vaccine in nonhuman primates
19. 2729. mRNA Vaccines Encoding Conserved Influenza Antigens Induce Robust and Durable Immunity in Rhesus Macaques
20. 2592. Lung Function as an Indicator of Vaccine Enhanced RSV Disease in Cotton Rats
21. Vaccine-induced cellular responses control acute SIV replication after heterologous challenge
22. The positions of 12 simple sequence repeat markers relative to reference loci on mouse Chromosome 16
23. Preclinical study of influenza virus A M2 peptide conjugate vaccines in mice, ferrets, and rhesus monkeys
24. Respiratory syncytial virus elicits enriched CD8+ T lymphocyte responses in lung compared with blood in African green monkeys
25. Genetic Stability of Parainfluenza Virus 5-Vectored Human Respiratory Syncytial Virus Vaccine Candidates after In Vitro and In Vivo Passage
26. A Single-Dose Recombinant Parainfluenza Virus 5-Vectored Vaccine Expressing Respiratory Syncytial Virus (RSV) F or G Protein Protected Cotton Rats and African Green Monkeys from RSV Challenge
27. Structure-based Design of Cyclically Permuted HIV-1 gp120 Trimers That Elicit Neutralizing Antibodies
28. Respiratory syncytial virus elicits enriched CD8+ T lymphocyte responses in lung compared with blood in African green monkeys.
29. Hemagglutinin Sequence Conservation Guided Stem Immunogen Design from Influenza A H3 Subtype
30. Influenza hemagglutinin stem-fragment immunogen elicits broadly neutralizing antibodies and confers heterologous protection
31. In vitro and in vivo characterization of designed immunogens derived from the CD-helix of the stem of influenza hemagglutinin
32. Design of Escherichia coli-Expressed Stalk Domain Immunogens of H1N1 Hemagglutinin That Protect Mice from Lethal Challenge
33. Small Molecule Mimetics of an HIV-1 gp41 Fusion Intermediate as Vaccine Leads
34. O3‐07‐03: A novel multivalent Abeta peptide vaccine with preclinical evidence of a central immune response that generates antisera recognizing a wide range of Abeta peptide species
35. Robust, Vaccine-Induced CD8+ T Lymphocyte Response against an Out-of-Frame Epitope
36. Vaccine-Induced Cellular Responses Control Simian Immunodeficiency Virus Replication after Heterologous Challenge
37. Characterizations of four monoclonal antibodies against M2 protein ectodomain of influenza A virus
38. Early depletion of proliferating B cells of germinal center in rapidly progressive simian immunodeficiency virus infection
39. Hemagglutinin sequence conservation guided stem immunogen design from influenza A H3 subtype.
40. Design of immunogens that present the crown of the HIV-1 V3 loop in a conformation competent to generate 447-52D-like antibodies
41. Vaccine-Induced Cellular Immune Responses Reduce Plasma Viral Concentrations after Repeated Low-Dose Challenge with Pathogenic Simian Immunodeficiency Virus SIVmac239
42. Vectored Gag and Env but Not Tat Show Efficacy against Simian-Human Immunodeficiency Virus 89.6P Challenge in Mamu-A * 01-Negative Rhesus Monkeys
43. Characterization of gp120 and Its Single-Chain Derivatives, gp120-CD4 D12 and gp120-M9: Implications for Targeting the CD4 i Epitope in Human Immunodeficiency Virus Vaccine Design
44. Enhancement of α-helicity in the HIV-1 inhibitory peptide DP178 leads to an increased affinity for human monoclonal antibody 2F5 but does not elicit neutralizing responses in vitro. Implications for vaccine design.
45. Enhancement of α-Helicity in the HIV-1 Inhibitory Peptide DP178 Leads to an Increased Affinity for Human Monoclonal Antibody 2F5 but Does Not Elicit Neutralizing Responses in Vitro
46. High throughput mutation screening of the factor VIII gene (F8C) in hemophilia A: 37 novel mutations and genotype-phenotype correlation
47. Caucasian family with two independent mutations: 2594delC inBRCA1 and 5392delAG inBRCA2 gene
48. High-Resolution Mapping of D16Led-1, Gart, Gas-4, Cbr, Pcp-4, and Erg on Distal Mouse Chromosome 16
49. Vaccination with peptide mimetics of the gp41 prehairpin fusion intermediate yields neutralizing antisera against HIV-1 isolates.
50. A novel multivalent Abeta peptide vaccine with preclinical evidence of a central immune response that generates antisera recognizing a wide range of Abeta peptide species
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.